The Hindu and VIT to host biotechnology conclave in September with industry leaders
VIT Chennai and The Hindu host conclave on biotechnology's role in healthcare, pharmaceuticals and sustainability. Features industry leaders and experts.
The Hindu and Vellore Institute of Technology, Chennai will convene a day-long conclave on the evolving role of biotechnology in healthcare, pharmaceuticals and sustainability in Chennai on September 11, 2026.
Dr. Suchitra Ella, co-founder and managing director of Bharat Biotech and CII-president designate, will deliver the inaugural address, while G. Viswanathan, founder and chancellor of VIT, will preside over the event. The conclave is designed to connect higher secondary students, undergraduates, researchers and biotechnology aspirants with experts across the field.
Experts and themes
The programme will feature Professor K. VijayRaghavan, Dr. Vasan Sambandamurthy, Dr. Vinod Scaria, Dr. Ganapathy, Dr. Maneesh Paul, Dr. Kalpana Gowrishankar, Mayur Abhaya and Ajay Mahipal, among others.
Sessions will focus on technology's role in accelerating biotechnology research, gene editing and precision medicine, India's position as a global biopharma hub, the country's research and innovation ecosystem, and funding avenues for biotechnology research.
Why it matters
"Biotechnology represents one of the most consequential frontiers of education and research, with the power to improve lives and address some of society's most urgent challenges," G. V. Selvam, vice-president, VIT, said. "Through this conclave, VIT Chennai aims to encourage students to see biotechnology not only as a field of study, but as a pathway to innovation, enterprise, and meaningful service to humanity".
Sundar Kondur, chief revenue officer, The Hindu Group, said the conclave is "an opportunity to bring meaningful, accessible and forward-looking conversations on science to young audiences". "By convening students, researchers, experts and industry voices on one platform, we hope to deepen public engagement with biotechnology and inspire informed curiosity about the field's role in India's future".
The event will be streamed live at https://newsth.live/VITBTCLS.
Source: The Hindu
Frequently asked questions
When and where is the biotechnology conclave being held?
The conclave will be held on September 11, 2026, in Chennai. It is a day-long event organized by The Hindu and Vellore Institute of Technology (VIT).
Who is delivering the inaugural address?
Dr. Suchitra Ella, co-founder and managing director of Bharat Biotech and CII-president designate, will deliver the inaugural address. G. Viswanathan, founder and chancellor of VIT, will preside over the event.
Who should attend this conclave?
The conclave is designed to connect higher secondary students, undergraduates, researchers, and biotechnology aspirants with experts across the field.
What topics will be covered during the sessions?
Sessions will focus on technology's role in accelerating biotechnology research, gene editing and precision medicine, India's position as a global biopharma hub, the country's research and innovation ecosystem, and funding avenues for biotechnology research.
How can I watch the event if I cannot attend in person?
The event will be streamed live at https://newsth.live/VITBTCLS.
You may also like
National
If there can be housewives, there can be house husbands also; let
Politics
Tamil Nadu Congress leader says he told Chennai Police about Veer
Accident
Delivery agent dies after container truck hits two-wheeler, flees scene
Crime
Police bust drug smuggling ring with 600 narcotic tablets seized at railway station
Most read
- 1
Tesla audits Chinese suppliers to scale up Optimus robot production
- 2
Former minister Lakhan Singh Rajput to inaugurate temple bhandara at Shri Chakreshwar Mahadev
- 3
Firozabad BSA finds four government schools locked during inspection
- 4
Tamil Nadu dengue cases fall for third consecutive year to 17,049
- 5
Social workers stage silent protest at Fufund railway station for train halts
Comments
No comments yet. Be the first to comment.